MENU
+Compare
CTXR
Stock ticker: NASDAQ
AS OF
Sep 26, 03:19 PM (EDT)
Price
$1.15
Change
-$0.00 (-0.00%)
Capitalization
19.56M

CTXR Citius Pharmaceuticals Inc Forecast, Technical & Fundamental Analysis

Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy... Show more

CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CTXR with price predictions
Sep 25, 2025

CTXR's Stochastic Oscillator stoops into oversold zone

The Stochastic Oscillator for CTXR moved into oversold territory on September 25, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for CTXR just turned positive on September 24, 2025. Looking at past instances where CTXR's MACD turned positive, the stock continued to rise in of 44 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTXR advanced for three days, in of 228 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on September 19, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CTXR as a result. In of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTXR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for CTXR entered a downward trend on September 02, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.301) is normal, around the industry mean (19.661). P/E Ratio (0.000) is within average values for comparable stocks, (53.961). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.097). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (344.769).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CTXR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTXR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
CTXR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
11 Commerce Drive
Phone
+1 908 967-6677
Employees
22
Web
https://www.citiuspharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BCTX10.710.35
+3.38%
Briacell Therapeutics Corp NEW
PRU102.62-0.70
-0.68%
Prudential Financial
TNL59.64-0.74
-1.23%
Travel + Leisure Co
CMT21.48-0.39
-1.78%
Core Molding Technologies
GHRS13.40-0.51
-3.67%
GH Research PLC

CTXR and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTXR has been loosely correlated with KLTO. These tickers have moved in lockstep 36% of the time. This A.I.-generated data suggests there is some statistical probability that if CTXR jumps, then KLTO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTXR
1D Price
Change %
CTXR100%
-3.36%
KLTO - CTXR
36%
Loosely correlated
-5.58%
EVGN - CTXR
35%
Loosely correlated
-4.72%
HYPD - CTXR
33%
Loosely correlated
-11.97%
ALEC - CTXR
29%
Poorly correlated
-7.28%
VYGR - CTXR
29%
Poorly correlated
-3.76%
More